- You are here:
-
Home
- News
News
- Details
- Category: POZ.com
The company also has plans to study monthly islatravir’s efficacy as HIV prevention among men who have sex with men.
- Details
- Category: POZ.com
A study looked at the fat composition of people who switched their antiretrovirals to include an integrase inhibitor.
- Details
- Category: POZ.com
Long-acting injectable cabotegravir for HIV prevention could hit the market for men and women in early 2022.
- Details
- Category: POZ.com
The study in Vietnam examined the effects of an intervention based in cognitive behavioral and motivational enhancement therapy.
- Details
- Category: POZ.com
Gilead Sciences presented findings from several studies of the single-tablet antiretroviral regimen at a recent scientific meeting.
- Details
- Category: POZ.com
You’ve heard about the 90-90-90 HIV targets. But what about measuring quality of life? Bob Leahy wonders about adding a fourth 90.
- Details
- Category: POZ.com
Their global conference also launched the 13 Million Campaign, an effort to get health services to those with HIV and not on meds.
- Details
- Category: POZ.com
Five albums from the series will be released digitally. Remixes of Neneh Cherry’s 1990 take on “I’ve Got You Under My Skin” are out no...
- Details
- Category: POZ.com
More studies link dolutegravir and other drugs to weight gain among people with HIV.
Subcategories
Fundraisers Article Count: 2
Health Article Count: 4
HIV / AIDS Article Count: 4
Partners Article Count: 387
POZ.com Article Count: 386
POZ Stories Article Count: 50
Page 9 of 34
- You are here:
-
Home
- News